Julia Bohlius
Julia Bohlius
University of Bern, Institute of Social and Preventive Medicine
Verified email at ispm.unibe.ch
Title
Cited by
Cited by
Year
2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with …
MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ...
European journal of cancer 47 (1), 8-32, 2011
9212011
Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients
J Bohlius, J Wilson, J Seidenfeld, M Piper, G Schwarzer, J Sandercock, ...
Journal of the National Cancer Institute 98 (10), 708-714, 2006
7262006
Recombinant human erythropoiesis-stimulating agents and mortality in patients with cancer: a meta-analysis of randomised trials
J Bohlius, K Schmidlin, C Brillant, G Schwarzer, S Trelle, J Seidenfeld, ...
The Lancet 373 (9674), 1532-1542, 2009
6242009
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and …
MS Aapro, DA Cameron, R Pettengell, J Bohlius, J Crawford, M Ellis, ...
European journal of cancer 42 (15), 2433-2453, 2006
5872006
Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis
H Schulz, JF Bohlius, S Trelle, N Skoetz, M Reiser, T Kober, G Schwarzer, ...
Journal of the National Cancer Institute 99 (9), 706-714, 2007
4082007
Erythropoietin or darbepoetin for patients with cancer
J Bohlius, J Wilson, J Seidenfeld, M Piper, G Schwarzer, J Sandercock, ...
Cochrane Database of Systematic Reviews, 2006
401*2006
Recombinant human erythropoietin and overall survival in cancer patients: results of a comprehensive meta-analysis
J Bohlius, S Langensiepen, G Schwarzer, J Seidenfeld, M Piper, ...
Journal of the National Cancer Institute 97 (7), 489-498, 2005
2952005
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update
JD Rizzo, MR Somerfield, KL Hagerty, J Seidenfeld, J Bohlius, CL Bennett, ...
Journal of Clinical Oncology 26 (1), 132-149, 2008
2882008
American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
JD Rizzo, M Brouwers, P Hurley, J Seidenfeld, MO Arcasoy, JL Spivak, ...
Blood 116 (20), 4045-4059, 2010
2402010
Erythropoietin or darbepoetin for patients with cancer
T Tonia, A Mettler, N Robert, G Schwarzer, J Seidenfeld, O Weingart, ...
Cochrane database of systematic reviews, 2012
2272012
Granulopoiesis‐stimulating factors to prevent adverse effects in the treatment of malignant lymphoma
J Bohlius, C Herbst, M Reiser, G Schwarzer, A Engert
Cochrane Database of Systematic Reviews, 2008
2132008
The erythropoietin receptor in normal and cancer tissues
W Jelkmann, J Bohlius, M Hallek, AJ Sytkowski
Critical reviews in oncology/hematology 67 (1), 39-61, 2008
1842008
A systematic review and economic evaluation of epoetin alfa, epoetin beta and darbepoetin alfa in anaemia associated with cancer, especially that attributable to cancer treatment
J Wilson, GL Yao, J Raftery, J Bohlius, S Brunskill, J Sandercock, ...
NIHR Health Technology Assessment programme: Executive Summaries, 2007
1832007
American Society of Clinical Oncology/American Society of Hematology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer
JD Rizzo, M Brouwers, P Hurley, J Seidenfeld, MR Somerfield, S Temin
Journal of oncology practice 6 (6), 317-320, 2010
1762010
European Organisation for Research and Treatment of Cancer. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of …
MS Aapro, J Bohlius, DA Cameron, L Dal Lago, JP Donnelly, N Kearney, ...
Eur J Cancer 47 (1), 8-32, 2011
1662011
Use of epoetin and darbepoetin in patients with cancer: 2007 American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update
JD Rizzo, MR Somerfield, KL Hagerty, J Seidenfeld, J Bohlius, CL Bennett, ...
Blood 111 (1), 25-41, 2008
1562008
Cancer-related anemia and recombinant human erythropoietin—an updated overview
J Bohlius, O Weingart, S Trelle, A Engert
Nature clinical practice oncology 3 (3), 152-164, 2006
1322006
High‐dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non‐Hodgkin lymphoma (NHL) in adults
A Greb, J Bohlius, D Schiefer, G Schwarzer, H Schulz, A Engert
Cochrane Database of Systematic Reviews, 2008
1302008
High-dose chemotherapy with autologous stem cell support in first-line treatment of aggressive non-Hodgkin lymphoma–results of a comprehensive meta-analysis
A Greb, J Bohlius, S Trelle, D Schiefer, CA De Souza, C Gisselbrecht, ...
Cancer treatment reviews 33 (4), 338-346, 2007
1292007
Chemotherapy plus Rituximab versus chemotherapy alone for B‐cell non‐Hodgkin's lymphoma
H Schulz, J Bohlius, N Skoetz, S Trelle, T Kober, M Reiser, M Dreyling, ...
Cochrane Database of Systematic Reviews, 2007
1272007
The system can't perform the operation now. Try again later.
Articles 1–20